Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $9.31 and traded as high as $9.61. Cipher Pharmaceuticals shares last traded at $9.55, with a volume of 5,265 shares.
Cipher Pharmaceuticals Price Performance
The company’s 50-day moving average price is $9.31 and its two-hundred day moving average price is $9.21.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
See Also
- Five stocks we like better than Cipher Pharmaceuticals
- How to Short Nasdaq: An Easy-to-Follow Guide
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- Investing in Commodities: What Are They? How to Invest in Them
- Is IBM’s AI Transformation Powering a Sustained Rally?
- There Are Different Types of Stock To Invest In
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
